[pubmed] Introduction of an anticholinesterase drug in the context of myasthenia, in a severe asthmatic patient
Posté : 06 déc. 2021 12:00
Rev Mal Respir. 2021 Dec 2:S0761-8425(21)00400-9. doi: 10.1016/j.rmr.2021.11.001. Online ahead of print.
ABSTRACT
Association of asthma with myasthenia gravis presents a twofold peculiarity. First, as dyspnea characterizes both conditions, diagnostic orientation is difficult. Second, from a therapeutic standpoint, the initiation of anticholinesterase treatment requires a multidisciplinary approach due to possible contraindication for asthma. We report on the case of a patient monitored for severe asthma and treated with biotherapy, and also monitored for myasthenia gravis, and treated with anticholinesterase.
PMID:34865952 | DOI:10.1016/j.rmr.2021.11.001
Source: https://pubmed.ncbi.nlm.nih.gov/3486595 ... 5&v=2.15.0